Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
additional information
?
-
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
additional information
?
-
identification of L-Glu as the amino acid substrate activated by AmbE and loaded onto its T1 domain. The enzyme is also active with L-alanine instead of L-glutamate, but only in presence of the L-alanine-[L-alanyl-carrier protein] ligase AmbB (cf. EC 6.2.1.67), AmbB-dependent loading of L-Ala onto the T2 domain of AmbE, overview. Analysis of enzyme peptide fragment binding with substrate, peptide analysis by mass spectrometry, overview
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
(L-glutamyl)adenylate + holo-[L-glutamyl-carrier protein]
AMP + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate
diphosphate + (L-glutamyl)adenylate
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
ATP + L-glutamate + holo-[L-glutamyl-carrier protein]
AMP + diphosphate + L-glutamyl-[L-glutamyl-carrier protein]
-
-
-
ir
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
metabolism
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
metabolism
-
Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB)is a non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of AMB requires a five-gene cluster encoding a putative LysE-type transporter (AmbA), two non-ribosomal peptide synthetases (AmbB and AmbE, EC 6.2.1.67 and EC 6.2.1.68, respectively), and two iron(II)/alpha-ketoglutarate-dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation (T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is generated by a processing step from a precursor tripeptide assembled on a thiotemplate. The AmbB substrate is identified to be L-alanine (L-Ala), while the T1 and T2 domains of AmbE are loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2 of AmbE occurs only in the presence of AmbB, indicative of a trans loading mechanism. In vitro assays performed with AmbB and AmbE result in the dipeptide L-Glu-L-Ala at T1 and the tripeptide L-Ala-L-Glu-L-Ala attached at T2. When AmbC and AmbD are included in the assay, these peptides are no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide is found at T2, importance of flanking L-Ala residues in the precursor tripeptide
-
physiological function
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
physiological function
-
the enzyme is involved in biosynthesis of Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which proceeds via a precursor tripeptide. Identification of the building blocks of AMB biosynthesis and modelling, assembly of a tripeptide AmbB precursor on AmbE, overview
-
additional information
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
additional information
-
enzyme AmbE presents the typical modular structure of non-ribosomal peptide synthetases (NRPSs)
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
additional information
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
additional information
-
modular structure of AmbE with domains for adenylation, thiolation, condensation, methylation, and thioester cleavage. AmbE may have an additional domain of unknown function at its N-terminus and the C domain is atypical, domain architecture, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D644A
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
D644A/K1230T/S1985A
site-directed mutagenesis, the mutations abolish loading of L-Glu completely
K1230T
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
S1286A
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
S1819A
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
S1958A
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
D644A
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
K1230T
-
site-directed mutagenesis, amino acid alterations in the A domain abolish loading of L-Glu entirely
-
S1286A
-
site-directed mutagenesis, the mutation abolishes loading of L-Glu almost completely
-
S1819A
-
site-directed mutagenesis, mutation of S1819 does not interfere with loading of L-Glu
-
S1958A
-
site-directed mutagenesis, mutation of the active site Ser (S1958) of the TE domain does not interfere with loading of L-Glu
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.